ADAM19 belongs to the ADAM (a disintegrin and metalloproteinase) family that comprises transmembrane and secreted proteins and is found to be highly expressed in various human carcinomas including breast invasive carcinoma (BRCA) (Fig. S11). This evidence concerns the gene ADAM19 and carcinoma.